Randomized Placebo-Controlled Trial of Intravenous Immunoglobulin in Autoimmune LGI1/CASPR2 Epilepsy.

Ann Neurol · 2020 · PMC7003900 · PMID 31782181

Europe PMC DOI

hedged sentence

0.0770

closest p · 1.5× alpha

0.0770

boldest claim

The sentences

showed a trendp = 0.077so close (0.05 < p ≤ 0.1)

Secondary Outcome The median change in RBANS total score among LGI1‐IgG seropositive patients showed a trend toward improvement for the IVIG group compared to placebo (3 [0 to 13] vs −1 [−12 to 6], p = 0.077, 95% CI = 0.84–∞; Table 3 ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.